Cusatuzumab |
Catalog No.GC66356 |
Cusatuzumab은 인간 αCD70 단클론 항체입니다. 821d96072c2d58d8970e76f526b0f6b8Cusatuzumab은 향상된 항체 의존성 세포로 세포 독성 활성을 나타냅니다. 821d96072c2d58d8970e76f526b0f6b8Cusatuzumab은 백혈병 줄기 세포(LSC)를 감소시키고 골수 분화 및 세포 사멸과 관련된 유전자 서명을 유발합니다. 821d96072c2d58d8970e76f526b0f6b8Cusatuzumab은 급성 골수성 백혈병(AML) 연구에 잠재력이 있습니다.821d96072c2d58d8970e76f526b0f6b8
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1864871-20-4
Sample solution is provided at 25 µL, 10mM.
Cusatuzumab is a human αCD70 monoclonal antibody. Cusatuzumab shows cytotoxicity activity with enhanced antibody-dependent cellular. Cusatuzumab reduces leukemia stem cells (LSCs) and triggers gene signatures related to myeloid differentiation and apoptosis. Cusatuzumab has the potential for the research of Acute myeloid leukemia (AML)[1].
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *